🇺🇸 FDA
Patent

US 10231903

Pharmaceutical compounding methods and systems

granted A61KA61K31/045A61K31/135

Quick answer

US patent 10231903 (Pharmaceutical compounding methods and systems) held by MEDISCA PHARMACEUTIQUE INC. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MEDISCA PHARMACEUTIQUE INC.
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/045, A61K31/135, A61K31/137, A61K31/192